| Publications |
(Currently 512486 Items)
|
 |
| Partners |
|
|
|
| BIOTECHNOLOGY / Total: 9100 |
PREVIOUS | 1
| 2
| 3
| 4
| 5
| 6
| 7
| 8
| 9
| 10
| 11
| 12
| 13
|
NEXT 
|
| Title |
Date |
Price |
|
The Miravant Medical Technologies Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The Molecular Devices Corp Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Mar, 2006 |
€375 |
|
The Momenta Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The Monogram Biosciences Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The Monsanto Company Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Oct, 2006 |
€375 |
|
Horizon BlueCross BlueShield of New Jersey (Horizon BCBSNJ) is the states largest health insurer, providing coverage to over 2.8 million people. Horizon BCBSNJ has annual revenues of over $5.9 billion... |
Apr, 2004 |
€369 |
|
The MultiCell Technologies Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The Mylan Laboratories Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The Myogen Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Oct, 2006 |
€375 |
|
The Myriad Genetics Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The Nabi Biopharmaceuticals Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The Nanophase Technologies Corporation Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products... |
Mar, 2006 |
€375 |
|
The Nastech Pharmaceutical Co Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The Natrol Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The NatureWell Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The Novavax Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
Our BusIntell Report provides the information and analysis you need on MedImpact Health Systems to gain an understanding of what makes the company one of the leading pharmacy benefit managers in the country.... |
Nov, 2006 |
€369 |
|
The Novelos Therapeutics Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The Noven Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The Novogen Limited Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
|
|
|
